Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00417157
Status:
COMPLETED
Last Update Posted:
2013-12-16
First Post:
2006-12-22
Brief Title:
Modified Natural Cycle Offers a Chance of Pregnancy in Patients With Poor Response and High Basal FSH
Sponsor:
Eugonia
Organization:
Eugonia
Study Overview
Official Title:
Successful Application of Modified Natural Cycle in Poor Responders With High Basal FSH Prior to Oocyte Donation
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effectiveness of a modified natural cycle in patients with previous poor response to infertility drugs and high basal FSH prior to proceeding to oocyte donation or abandoning fertility treatment
Detailed Description:
Poor responders are a diverse group of IVF patients who fail to respond to IVF drugs In these patients pregnancy rates remain disappointingly low and usually oocyte donation is their only viable option The need for lengthy ovarian stimulation regimes can be avoided by performing IVF during a natural menstrual cycle However the main problem with a natural cycle is that successful IVF outcome can be compromised by a premature LH surge This problem can be solved by the administration of GnRH antagonists that suppress endogenous gonadotropin levels comprising a modified natural cycle MNC Previous studies have shown that MNC offers no realistic chances of pregnancy prior to oocyte donation In this study we will re-assess this view by showing that MNC offers some albeit small chances of positive IVF outcome in patients with known previous poor response prior to oocyte donation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None